v-Ha-ras encoded p21 protein (p21V), the cellular c-Ha-ras encoded protein (p21C) and its T24 mutant form P21T were produced in Escherichia coli under the control of the tac promoter. Large amounts of the authentic proteins in a soluble form can be extracted and purified without the use of denaturants or detergents. All three proteins are highly active in GDP binding, GTPase and, for p2lv, autokinase activity. Inhibition of [3H]GDP binding to p21C by regio-and stereospecific phosphorothioate analogs of GDP and GTP was investigated to obtain a measure of the relative affinities of the three diphosphate and five triphosphate analogs of guanosine. p21 has a preference for the Sp isomers of GDPaS and GTPaS. It has low specificity for the Sp isomer of GTP,BS. Together with the data for GDP,BS and GTP-yS these results are compared with those obtained for elongation factor (EF)-Tu and transducin. This has enabled us to probe the structural relatedness of these proteins. We conclude that p21 seems to be more closely related to EF-Tu than to transducin.
Transfection of cells with the H-2Kk gene lacking the transmembrane and cytoplasmic segments resulted in secretion of the H-2Kk protein, as determined by immunoprecipitation with monoclonal anti-H-2Kk antibodies. Transgenic (H-2b x H-2d)Fj mice were established carrying integrated copies of the modified H-2Kk gene. Expression of the soluble H-2Kk antigen in the transgenic mice was demonstrated in cell supernatants of biosynthetically labeled splenic and thymic Con A blasts as well as bone marrow-derived macrophages. Soluble H-2Kk molecules were also present in the sera of the transgenic animals. No cell-surface expression of the H-2Kk antigen could be observed. In spite of the presence of the soluble H-2Kk molecules in the transgenic mice, the animals were able to generate H-2Kk specific cytolytic T cells as well as antibody responses when stimulated with cell-surface-bound H-2K" antigens. These responses were indistinguishable from those of the nontransgenic littermates. Possible explanations for the observed lack of tolerance are discussed.The selection of the T-cell repertoire results in T cells that recognize foreign antigens only in association with the major histocompatibility complex (MHC) antigens (1). These T cells react also with high frequency with allogeneic MHC antigens, possibly due to crossreactivity (2). It is assumed that this selection takes place in the thymus, where T cells with high affinity for self MHC antigens are eliminated, resulting in tolerance for self MHC determinants. The mechanism of these selection processes is not understood. It is known that the presence of MHC molecules in the thymus is mandatory, but it is not clear if these MHC molecules have to be expressed as integral membrane proteins or if soluble MHC antigens are sufficient for induction of tolerance and education of T cells. Transgenic mice expressing a soluble "foreign" transplantation antigen should help to clarify this question.A prerequisite for this study is the conversion of membrane-associated proteins into secreted forms, a process that can be achieved by deletion of gene segments encoding the transmembrane portion of the protein (3). In this paper, we describe such a modification of the H-2Kk gene that leads to secretion of H-2Kk molecules by transfected cells. We also show that transgenic mice carrying the modified gene secrete the soluble H-2Kk protein into their serum. Immunological studies demonstrate that the presence of soluble H-2Kk proteins in these mice does not cause tolerance in cytolytic T lymphocyte (CTL) precursors and B cells specific for cell-surface-bound H-2Kk antigens.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.